Koninklijke DSM (RDSMY) Stock Price, News & Analysis

Company Overview

Koninklijke DSM N.V. was a Netherlands-based science and nutrition company that developed ingredients, materials and solutions for the nutrition, health, beauty and bioscience markets. Its offerings included vitamins, nutritional lipids, enzymes, specialty ingredients, food and beverage components, personal-care ingredients, and fragrance and taste solutions for consumer and industrial customers.

The company began in 1902 as the Dutch State Mines, or “De Nederlandse Staatsmijnen,” and gradually moved away from coal mining into chemicals, biotechnology and specialty materials. Over time, DSM expanded through research, acquisitions and international operations, serving customers across Europe, North America, Asia and other global markets.

In May 2023, Koninklijke DSM completed its merger with Firmenich, creating dsm-firmenich, a combined company focused on nutrition, health, beauty, taste and fragrance. The former DSM business is therefore primarily represented within dsm-firmenich rather than operating as a standalone public company. Dimitri de Vreeze serves as dsm-firmenich’s chief executive officer.

Key Stats

• Today's Range: $33.11 to $33.90
• 50-Day Range: $33.85 to $33.85
• 52-Week Range: $26.59 to $56.92
• Volume: 56,500 shs
• Average Volume: 116,034 shs
• Market Capitalization: $23.67 billion
• P/E Ratio: N/A
• Dividend Yield: 1.09%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/03/2020
• Today: 10/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RDSMY
• Previous Symbol: NASDAQ:RDSMY
• CIK: 877016
• Web: www.dsm.com
• Phone: (145) 578-8111
• Fax: 31-45-571-9753
• Employees: 21,358
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.30
• Current Ratio: 2.51
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: $10.89 billion
• Price / Sales: 2.17
• Cash Flow: $2.29 per share
• Price / Cash Flow: 14.80
• Book Value: $11.78 per share
• Price / Book: 2.87

Miscellaneous

• Outstanding Shares: 699,144,000
• Free Float: N/A
• Market Cap: $23.67 billion
• Optionable: Not Optionable
• Beta: 1.00